Raeliva in brief
Raeliva is a new telehealth brand selling compounded semaglutide and tirzepatide as shots or under-the-tongue tablets. Semaglutide injections are $219 month to month or $150 a month prepaid for six; tirzepatide $299 or $242. Good for flat pricing at every dose; the catch is upfront billing on longer plans.
- PriceFrom $219/mo (or $150/mo prepaid)
Assume we may earn a commission, at no cost to you. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
- Semaglutide
- From $219/mo (month to month, all doses, compounded)
- Tirzepatide
- From $299/mo (month to month, all doses, compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
Raeliva pricing
As listed on Raeliva's own site, October 2026.
| Plan | Price | Billing | What's included |
|---|---|---|---|
| Compounded semaglutide injection | Price $219/mo | Billing Monthly; $500 per 3 months or $900 per 6 months, paid upfront | Includes Medication, provider review, refill check-ins, refrigerated shipping |
| Compounded tirzepatide injection | Price $299/mo | Billing Monthly; $800 per 3 months or $1,450 per 6 months, paid upfront | Includes Medication, provider review, refill check-ins, refrigerated shipping |
| Semaglutide dissolving tablets | Price $260/mo | Billing Monthly; $550 per 3 months or $1,000 per 6 months | Includes Daily under-the-tongue tablet, no refrigeration |
| Tirzepatide dissolving tablets | Price $359/mo | Billing Monthly; $850 per 3 months or $1,600 per 6 months | Includes Daily under-the-tongue tablet, no refrigeration |
| Microdose semaglutide or tirzepatide | Price $149/mo | Billing Monthly only; labs may cost extra | Includes Low fixed weekly dose for metabolic support, not weight loss |
Our take on Raeliva
This review covers Raeliva as it appears in October 2026. Raeliva says it was founded in 2026. Its About page is unusually candid about who does what: the brand and website are run by Pacific Shores Research Group in San Diego, while the intake, telehealth visit, prescription and billing are handled by a partner company, CareValidate, based in Georgia. Prescriptions are filled by state-licensed compounding pharmacies, and compounded drugs are not FDA-approved.
The menu is compact and clearly priced. Compounded semaglutide injections are $219 on a monthly plan, $500 every three months ($167 a month) or $900 every six ($150 a month). Compounded tirzepatide injections are $299 monthly, $800 per three months or $1,450 per six, which works out to $242 a month. The dissolving tablets cost more: semaglutide tablets run $260 monthly down to $167 a month on six months, and tirzepatide tablets $359 monthly down to $267. The price stays the same as your dose goes up, and Raeliva says it never rises after the first bundle, though a promo code only applies to one order.
There is also a separate microdose track at $149 a month, monthly only, for both molecules. Raeliva is careful to present it as metabolic support within a longevity plan rather than a weight-loss treatment, and says labs may be billed separately on that track.
This suits someone who wants transparent numbers, likes the option of a needle-free tablet, and is fine with a brand that has little track record yet. Its refund terms are the usual for compounded medicine: once something is prescribed or shipped, the money is gone.
Signing up, paying and canceling
What Raeliva's own site shows a new patient.
- Multi-month plans are charged upfront in one payment, and the medication arrives in two shipments so the second box is not past its use-by date.
- Before each refill you get a check-in form, and a provider decides your next dose from your answers; you can also request a refill in the patient portal.
- To cancel, email support or message your care team by text or email; Raeliva promises written confirmation and no further charges once confirmed.
- Orders can only be canceled and refunded before the prescription is processed; refunds otherwise cover wrong medication or verified shipping errors.
- Raeliva ships to all 50 states but not abroad, and it does not bill insurance; FSA and HSA cards are accepted.
The scorecard
Raeliva scored on our six published factors. See the methodology.
What we like
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
- Multiple administration formats
The caveats
- Three- and six-month plans are billed upfront
- A new brand with a short public track record
Raeliva: common questions
Who runs Raeliva?
Raeliva says it was founded in 2026. Pacific Shores Research Group in San Diego runs the brand and website, while a partner company, CareValidate in Georgia, handles the intake, telehealth visit, prescribing and billing. Medication comes from state-licensed compounding pharmacies, and compounded drugs are not FDA-approved.
How much does Raeliva cost?
Compounded semaglutide injections are $219 month to month, or $150 a month when you prepay $900 for six months. Tirzepatide injections are $299 monthly or $242 a month on a $1,450 six-month plan. Tablets cost more, and a microdose track is $149 a month.
Can you cancel Raeliva anytime?
Yes. There is no contract or cancellation fee; email support or message your care team and wait for written confirmation. A refund is only possible if you cancel before the prescription is processed, so a prepaid three- or six-month plan is not refundable once filled.
Does Raeliva take insurance?
No. Raeliva is direct-pay only and does not bill insurance. FSA and HSA cards are accepted, and the company will email an itemized receipt if you want to submit it for reimbursement, though eligibility depends on your plan.
The verdict
Best for: Shoppers who want mainstream telehealth GLP-1 access. New telehealth brand selling compounded semaglutide and tirzepatide as shots or under-the-tongue tablets, at one price at every dose.
Ranked #140 of 539 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, ranked #1. In the ranking it sits between Luma Meds at #139, 71/100 above and PlexusDx at #141, 71/100 below, with the Recovery Delivered write-up the next one down.
Raeliva is one of 539 providers in this ranking, which makes the fair next question who sits above it — our shortlist of Raeliva alternatives answers it in order, with every score shown. For the wider picture, every review we have published ranks the field on the same six factors. We have also compared it head to head: CoreAge Rx vs Raeliva goes to CoreAge Rx, 94/100 to 71/100.
Compare Raeliva
Compare with other providers
The closest reviews to Raeliva by Verdict Score — the realistic shortlist if you are weighing this one up.
- #144TeleHealth Weight Solutions— TeleHealth Weight Solutions (branded Medi Health Clinics) is a nurse-practitioner-managed telehealth program prescribing compounded semaglutide and tirzepatide for weight loss, shipped with supplies from…71/100
- #145Tru2u— Tru2u is a US direct-to-consumer telehealth and wellness store offering provider-guided compounded GLP-1 weight-loss therapy alongside hair, skincare, and supplement lines.71/100
- #146Voxy— Voxy is a Scottsdale, Arizona telehealth practice offering compounded semaglutide and tirzepatide alongside NAD+ and sermorelin.71/100
- #147Oak— One price at every dose and no membership fee — but Oak publishes nine different "starting" prices, attaches a billing term to none of them, and will not name a rate until you have finished a 29-question intake.68/100
- #148MyDrHank— A six-shelf prescription telehealth catalog advertising compounded GLP-1s from $171 to $240 a month — but no page says which plan length those prices need, and the full price list stays hidden until you give a mobile number.68/100
- #149SkinnyRx— Sells compounded semaglutide and tirzepatide as a weekly shot or a daily tablet, with first-month prices on its home page — but no public page prints what month two costs.68/100
Pricing, states and verification reflect Raeliva's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Raeliva's site. Not medical advice; see our disclosure.